Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound

International Journal of Cardiology

Volumn 135, Issue 2, 2009, Pages 243-245

  Kaneda, Hideaki ^a   Ako, Junya ^a   Terashima, Mitsuyasu ^a   Waseda, Katsuhisa ^a   Yock, Paul G ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Angioplasty; Ultrasonography

Indexed keywords

RAPAMYCIN;

ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DIAGNOSTIC ACCURACY; DRUG ELUTING STENT; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 67349148112     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.01.054     Document Type: Article

References (13)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Colombo A., Orlic D., Stankovic G., et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107 (2003) 2178-2180
4. Kaneda H., Ako J., Kataoka T., et al. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 97 (2006) 340-342
5. Mintz G.S., Hong M.K., Raizner A.E., et al. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol 95 (2005) 107-109
6. Mauri L., Orav E.J., O'Malley A.J., et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111 (2005) 321-327
7. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455 [discussion 1455]
8. Costa M.A., Sabate M., Angiolillo D.J., et al. Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss. Catheter Cardiovasc Interv 69 (2007) 181-188
9. Nissen S.E., and Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 103 (2001) 604-616
10. Kastrati A., Mehilli J., Pache J., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
11. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
12. Luscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
13. de Vrey E.A., Mintz G.S., von Birgelen C., et al. Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy. J Am Coll Cardiol 32 (1998) 1874-1880